Published in Medical Patent Business Week, November 16th, 2007
As of September 30, 2007, Dynavax reported cash, cash equivalents, marketable securities and investments held by Symphony Dynamo, Inc. (SDI) totaling $68.7 million. This compares to $86.2 million at December 31, 2006.
"During the quarter, we made significant clinical progress and increased financial resources for our allergy and flu programs," said Dino Dina, MD, president and chief executive officer. "These events plus issuance of a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.